Komori
Governance4572Carna Biosciences,Inc.Pharmaceuticals

Articles of Incorporation 2026/03/25

The Articles of Incorporation were amended by the annual general meeting of shareholders on 25 March 2026. However, the text alone does not identify which provisions were amended this time.

Worth reading
55In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Governance structure

Company with an Audit and Supervisory Committee
Number of directorsUp to 10 directors, excluding directors who are Audit and Supervisory Committee members, and up to 4 directors who are Audit and Supervisory Committee members (total and outside director figures: Not disclosed)
Committee1
Audit and Supervisory Committee
Changes this time

The Articles of Incorporation are stated to have been amended at the annual general meeting of shareholders on 25 March 2026, but the specific amendments are Not disclosed

Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit and Supervisory Committee
Number of directorsUp to 10 directors, excluding directors who are Audit and Supervisory Committee members, and up to 4 directors who are Audit and Supervisory Committee members (total and outside director figures: Not disclosed)
CommitteeAudit and Supervisory Committee (proportion of outside members: Not disclosed)
Changes this timeThe Articles of Incorporation are stated to have been amended at the annual general meeting of shareholders on 25 March 2026, but the specific amendments are Not disclosed
Items this document does not state (4)
Number of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The amendment history of the Articles of Incorporation states, “25 March 2026: Amended at the annual general meeting of shareholders,” but does not give the reason for the amendment.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Articles of Incorporation 2026/03/25 | Carna Biosciences,Inc. (4572) timely disclosure | Komori